Corbus Pharmaceuticals Holdings, Inc. vs. Eli Lilly & Co.
Eli Lilly & Co. (LLY) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CRBP | LLY | |
|---|---|---|
| Market Cap | $75.72 million | $1.26 trillion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| CRBP | LLY | |
|---|---|---|
| Dividend Yield | — | 0.49% |
CRBP and LLY split the dividend factors evenly.
Risk & Sentiment
| CRBP | LLY | |
|---|---|---|
| Short Interest | 41.63% | 1.29% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: CRBP overview, CRBP financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.